Modeling, Chemistry, and Biology of the Benzolactam Analogues of Indolactam V (ILV). 2. Identification of the Binding Site of the Benzolactams in the CRD2 Activator-Binding Domain of PKCδ and Discovery of an ILV Analogue of Improved Isozyme Selectivity
Alan P. Kozikowski(Chembio (United States)), Peter M. Blumberg(National Cancer Institute), Krisztina Bögi(Georgetown University), Shayan Modarres(Georgetown University), Nancy E. Lewin(National Cancer Institute), Shaomeng Wang(University of Michigan), Robert I. Glazer(Georgetown University), Shakeel Ahmad(University of Lahore), Dawei Ma(Southern University of Science and Technology), Jiangchao Yao(Shanghai Jiao Tong University), Péter Ács(Georgetown University)
Cited by 72
Related Papers
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
|Cell|2011|817
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
|Cell Reports|2013|630
SAR405838: An Optimized Inhibitor of MDM2–p53 Interaction That Induces Complete and Durable Tumor Regression
|Cancer Research|2014|337
3D Bioprinting a Cell-Laden Bone Matrix for Breast Cancer Metastasis Study
|ACS Applied Materials & Interfaces|2016|300